How many clinical trials are studying Norepinephrine?

4 recruiting trials in our tracked data involve Norepinephrine.

What conditions is Norepinephrine being studied for?

In our tracked recruiting trials, Norepinephrine is being studied in trials for Atrial fibrillation, Healthy, Hypertension.

Yes. According to the FDA drug label available through openFDA, Norepinephrine is an FDA-approved drug.

Recruiting trials

Conditions studied

US states with sites

Countries

FDA-approved: Yes. Norepinephrine appears in the FDA drug-label database. Marketed as Norepinephrine.
Drug class: Catecholamine (FDA established pharmacologic class)

USES: For temporary relief of anxiety, mood swings, dizziness, skin rashes, fears, headaches, hives and hot flashes.

Reason (FDA)	Classification	Status	Initiated
GMP Deviation; A foreign stopper was observed during packaging of a lot of product. — Hospira Inc., A Pfizer Company	Class II (FDA: may cause temporary or reversible harm)	Terminated	2017-05-18
Incorrect product concentration on the overwrap label: The overwrap label incorrectly identified the product strength as 4 mg / 250 mL; however, the primary bag label correctly identified the product strength as 8 mg / 250 mL. — Baxter Healthcare Corporation	Class II (FDA: may cause temporary or reversible harm)	Ongoing	2024-01-23
Lack of sterility assurance: resulting from use of a damaged sterilizing filter for nitrogen used in the manufacturing process. — Pfizer Inc.	Class II (FDA: may cause temporary or reversible harm)	Terminated	2017-08-22
Failed Impurities/Degradation Specifications: Above the specification limits yielded for related substance norepinephrine sulfonic acid impurity during routine product monitoring. — SUN PHARMACEUTICAL INDUSTRIES INC	Class III (FDA: unlikely to cause harm)	Terminated	2023-03-29

Early Phase 1 1 Phase 4 2 Not applicable 1

Condition	Trials
Atrial fibrillation	1
Healthy	1
Hypertension	1
Hypotension and Shock	1
Hypoxemic Respiratory Failure	1
Obesity	1
Postpartum Hemorrhage	1
Pulmonary Hypertension of the Newborn (PPHN)	1
Shock	1
Type 2 diabetes	1
Vasodilation	1

Dopamine vs. Norepinephrine for Hypotension in Neonates With Pulmonary Hypertension (DONE)
NCT07322133 · Phase: Phase 4 · Ages: Up to 28 Days · Sex: All (male and female) · 1 location
Effect of Ephedrine, Phenylepinephrine, and Norepinephrine on Myometrial Contractility in Pregnant People With Type II and Gestational Diabetes During Cesarean Section: An In-vitro Study
NCT06285396 · Phase: Not applicable (e.g. observational or device study) · Ages: 19 Years to 45 Years · Sex: Female · 1 location
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
NCT05219799 · Phase: Early Phase 1 · Ages: 18 Years to 45 Years · Sex: All (male and female) · 1 location
Vasoactive Drugs in Intensive Care Unit
NCT02118467 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Yes, marketed as Norepinephrine.

4 recruiting trials across 11 conditions.

No. For the full record, search ClinicalTrials.gov.